Huh, Hyunbin D.
Sub, Yujin
Oh, Jongwook
Kim, Ye Eun
Lee, Ju Young
Kim, Hwa-Ryeon
Lee, Soyeon
Lee, Hannah
Pak, Sehyung
Amos, Sebastian E.
Vahala, Danielle
Park, Jae Hyung
Shin, Ji Eun
Park, So Yeon
Kim, Han Sang
Roh, Young Hoon
Lee, Han-Woong
Guan, Kun-Liang
Choi, Yu Suk
Jeong, Joon
Choi, Junjeong
Roe, Jae-Seok
Gee, Heon Yung
Park, Hyun Woo
Article History
Received: 21 November 2022
Accepted: 1 March 2023
First Online: 30 March 2023
Change Date: 14 August 2023
Change Type: Correction
Change Details: A Correction to this paper has been published:
Change Details: https://doi.org/10.1186/s12943-023-01838-3
Declarations
:
: Ethical approval for the use of human subjects was obtained from the Institutional Review Board of Gangnam Severance Hospital, Yonsei University, Seoul, Republic of Korea (3–2021-0236) in compliance with the ethical guidelines of the 1975 Declaration of Helsinki, and informed written consent was obtained from each patient. Collection of human breast cancer samples were obtained from consenting patients in accordance with guidelines and regulations approved by the Institutional Review Board of Gangnam Severance Hospital, Yonsei University Health System (3–2021-0236). The animal experiment protocols were reviewed and approved by the Yonsei University Institutional Animal Care and Use Committee (IACUC).
: The authors declare that they have no conflict of interests.